Correlation Between Eli Lilly and Reviva Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Eli Lilly and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eli Lilly and and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on Eli Lilly and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and Reviva Pharmaceuticals.
Diversification Opportunities for Eli Lilly and Reviva Pharmaceuticals
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Eli and Reviva is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of Eli Lilly i.e., Eli Lilly and Reviva Pharmaceuticals go up and down completely randomly.
Pair Corralation between Eli Lilly and Reviva Pharmaceuticals
Considering the 90-day investment horizon Eli Lilly is expected to generate 12.59 times less return on investment than Reviva Pharmaceuticals. But when comparing it to its historical volatility, Eli Lilly and is 25.18 times less risky than Reviva Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Reviva Pharmaceuticals Holdings is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 90.00 in Reviva Pharmaceuticals Holdings on August 30, 2024 and sell it today you would lose (67.00) from holding Reviva Pharmaceuticals Holdings or give up 74.44% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Eli Lilly and vs. Reviva Pharmaceuticals Holding
Performance |
| Timeline |
| Eli Lilly |
| Reviva Pharmaceuticals |
Eli Lilly and Reviva Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eli Lilly and Reviva Pharmaceuticals
The main advantage of trading using opposite Eli Lilly and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.| Eli Lilly vs. Emergent Biosolutions | Eli Lilly vs. Bausch Health Companies | Eli Lilly vs. Neurocrine Biosciences | Eli Lilly vs. Teva Pharma Industries |
| Reviva Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Reviva Pharmaceuticals vs. CannBioRx Life Sciences | Reviva Pharmaceuticals vs. Clene Inc | Reviva Pharmaceuticals vs. Lixte Biotechnology Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |